NL300541A - - Google Patents
Info
- Publication number
- NL300541A NL300541A NL300541DA NL300541A NL 300541 A NL300541 A NL 300541A NL 300541D A NL300541D A NL 300541DA NL 300541 A NL300541 A NL 300541A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL300541A true NL300541A (2) |
Family
ID=1879081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL300541D NL300541A (2) |
Country Status (1)
| Country | Link |
|---|---|
| NL (1) | NL300541A (2) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995021612A3 (en) * | 1993-02-08 | 1995-09-21 | Nps Pharma Inc | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| US6017965A (en) * | 1993-02-08 | 2000-01-25 | Nps Pharmaceuticals, Inc. | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| US6051610A (en) * | 1993-02-08 | 2000-04-18 | Nps Pharmaceuticals, Inc. | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| US6211245B1 (en) | 1993-02-08 | 2001-04-03 | Nps Pharmaceuticals, Inc. | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| US6750244B2 (en) | 1993-02-08 | 2004-06-15 | Nps Pharmaceuticals, Inc. | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| US7087765B2 (en) | 1995-06-07 | 2006-08-08 | Nps Pharmaceuticals, Inc. | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
-
0
- NL NL300541D patent/NL300541A/xx unknown
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995021612A3 (en) * | 1993-02-08 | 1995-09-21 | Nps Pharma Inc | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| US6017965A (en) * | 1993-02-08 | 2000-01-25 | Nps Pharmaceuticals, Inc. | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| US6051610A (en) * | 1993-02-08 | 2000-04-18 | Nps Pharmaceuticals, Inc. | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| US6071970A (en) * | 1993-02-08 | 2000-06-06 | Nps Pharmaceuticals, Inc. | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| US6211245B1 (en) | 1993-02-08 | 2001-04-03 | Nps Pharmaceuticals, Inc. | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| US6306912B1 (en) | 1993-02-08 | 2001-10-23 | Nps Pharmaceuticals, Inc. | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| US6750244B2 (en) | 1993-02-08 | 2004-06-15 | Nps Pharmaceuticals, Inc. | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| US7268166B2 (en) | 1993-02-08 | 2007-09-11 | Nps Pharmaceuticals, Inc. | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| EP1749522A3 (en) * | 1994-02-08 | 2010-10-27 | NPS Pharmaceuticals, Inc. | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| US7087765B2 (en) | 1995-06-07 | 2006-08-08 | Nps Pharmaceuticals, Inc. | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2004264667B2 (en) | Abuse-proofed dosage form | |
| EP0831799B1 (en) | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders | |
| US7160923B1 (en) | Polyamine analogues as therapeutic and diagnostic agents | |
| CN1067550C (zh) | 钙受体活性组合物的制备方法 | |
| EP1123922B1 (en) | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases | |
| AU2009239430B2 (en) | Compounds, compositions and methods for making the same | |
| US20140194455A1 (en) | Oxidation-stabilized tamper-resistant dosage form | |
| YU3275A (en) | Process for obtaining 3-aryloxy-3-phenylpropylamine compounds | |
| JP2001510181A5 (2) | ||
| EA201792345A1 (ru) | Защищенная от применения не по назначению лекарственная форма с немедленным высвобождением и устойчивостью к экстракции растворителями | |
| AU723349B2 (en) | Coumpounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases | |
| NZ221036A (en) | Diphenylpropylamine derivatives and pharmaceutical compositions | |
| GB2177701B (en) | Glutamate antagonists | |
| DE4239816A1 (de) | Arzneimittel zur Behandlung des zentralen Nervensystems | |
| WO2004105692A3 (en) | Smooth muscle spasmolytic agents | |
| WO1998056752A1 (en) | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases | |
| US20060142594A1 (en) | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |